Relmada Therapeutics, Inc. (RLMD) Institutional Ownership & Insider Trading
126 institutions reported holding Relmada Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 10 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RLMDRelmada Therapeutics, Inc.Follow RLMD — free
—
Price chart with a free account
- Market cap
- 348.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters126 institutions held 94.0% of the shares. Across filers that reported both quarters, shares held changed +20.0%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 126 | 100 | +20.0% | 34 | 46 | 20 | 22 |
| Mar 26 | 103 | 84 | +59.5% | 27 | 33 | 24 | 9 |
| Dec 25 | 77 | 51 | — | — | — | — | — |
| Sep 25 | 44 | 8 | +45.9% | 12 | 2 | 11 | 8 |
| Jun 25 | 50 | 5 | -14.7% | 5 | 13 | 13 | 6 |
| Mar 25 | 44 | 6 | -26.2% | 3 | 7 | 13 | 12 |
| Dec 24 | 47 | 8 | -34.0% | 10 | 5 | 15 | 27 |
| Sep 24 | 69 | 12 | -9.2% | 8 | 5 | 22 | 14 |
Relmada Therapeutics, Inc. — questions
- Who owns Relmada Therapeutics, Inc. stock?
- 126 institutions reported Relmada Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Jupiter Topco LLC (10.5%), BlackRock, Inc. (7.0%), Squadron Capital Management LLC (6.9%).
- Are Relmada Therapeutics, Inc. insiders buying or selling?
- 10 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Relmada Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.